TB vaccine development: monitoring international patent filings to anticipate access challenges
Our results show that there were patent filings in countries with existing manufacturing capacity, unveiling a corporate strategy to include those countries. The study anticipates the potential access challenges related to intellectual property barriers for expanding manufacturing capacity in middle-income countries to allow future TB vaccines to be available in a timely and equitably manner for those most in need.
Authors
- Mike Frick (ORCID: https://orcid.org/0000-0002-3316-1930)
- Sergiy Kondratyuk (ORCID: https://orcid.org/0009-0006-3950-8217)
- María Lorena Bacigalupo
- Carolinne Thays Scopel (ORCID: https://orcid.org/0000-0003-3254-2800)
- Gabriela Costa Chaves
- María Florencia Pignataro
Institutions
- Consejo Nacional de Investigaciones Científicas y Técnicas (AR)
- Treatment Action Group (US)
- Coalition for Epidemic Preparedness Innovations (NO)
- Instituto de Biotecnología y Biología Molecular (AR)
- National Academy of Legal Sciences of Ukraine (UA)
- Fundación Ciencias Exactas y Naturales (AR)
- Graduate Institute of International and Development Studies (CH)
Publication Details
- Journal
- Frontiers in Public Health
- Published
- 2026-01-16
- DOI
- https://doi.org/10.3389/fpubh.2025.1726153
- Primary Topic
- Tuberculosis Research and Epidemiology
- Type
- article
- Field-Weighted Citation Impact
- 0.00